Shock, Septic: all 890 studies

Page 6 of 9. Open to participants first (210), then studies with results posted, then the rest; newest registration first within each.

• A Multiple Centre, Cohort Study of New CRRT Membranes oXiris for Patients With Septic ShockCompletedNCT04073771
• Therapeutic Plasma Exchange in Adult Patients With Severe SepsisCompletedNCT04057872Phase 1
• Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic ShockActive, not recruitingNCT04055909Phase 2
• Predictors and Outcomes of Meropenem Treatment Failure Among Patients With Septic Shock in Intensive Care UnitStatus unknownNCT04042662
• Ivabradine for Heart Rate Control In Septic ShockCompletedNCT04031573Phase 3
• Adjuvant Therapy With CytoSorb in Refractory Septic ShockStatus unknownNCT04013269Not applicable
• Dexmedetomidine in Modifying Immune Paralysis In Patient With Septic ShockCompletedNCT03989609Phase 2
• Cirrhotic Patients With Septic ShockCompletedNCT03987048
• Evaluating a CytoSorb Score in Septic ShockCompletedNCT03977688
• Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Severe Septic ShockCompletedNCT03974386Not applicable
• Determination of the Dissociation Constant (Ka) of Plasma and Whole Blood in Septic PatientsStatus unknownNCT03966664
• Evaluation of New Hemodynamic IndicesStatus unknownNCT03961594Not applicable
• Evaluation of the Effect of Dexmedetomidine on Phenylephrine Response During Refractory Septic ShockTerminatedNCT03953677Phase 3
• Functional Magnetic Resonance Imaging (fMRI) of Brain in ICU Survivors With Cognitive ImpairmentCompletedNCT03946839
• Caretaker vs. Blood Pressure Monitoring With Invasive Arterial Pressure Monitoring in Patients With Septic ShockActive, not recruitingNCT03933722
• Proadrenomedullin and Microcirculation in Monitoring Organ Dysfunction in Patient With InfectionCompletedNCT03931967
• TelePORT Pilot StudyCompletedNCT03926533Not applicable
• Adjunctive Granisetron Therapy in Patients With Sepsis or Septic ShockCompletedNCT03924518Phase 2
• Prognostic Value Serum Concentration of Indoxyl Sulfate During Acute Kidney Injury in Septic Shock Patients.CompletedNCT03920982Not applicable
• Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine.CompletedNCT03913468
• Impact of Midodrine Administration on the Clinical Outcome of Septic Shock PatientsCompletedNCT03911817Phase 4
• Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label StudyCompletedNCT03901807Not applicable
• Microcirculatory Guided Goal Directed Fluid Therapy in Septic Shock; a Feasibility StudyStatus unknownNCT03898674Not applicable
• Effect of Fluid Challenge on GlycocalyxCompletedNCT03891342Not applicable
• Early Identification of Sepsis in ChildrenStatus unknownNCT03884595
• NIRS Directed Optimal Cerebral Perfusion Pressure in Septic Shock Patients: A Feasibility StudyStatus unknownNCT03879317
• Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic ShockCompletedNCT03872011Phase 3
• Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill CirrhoticsStatus unknownNCT03866083Not applicable
• Acute Intestinal Failure in Critically Ill Patients and Microbial TranslocationCompletedNCT03861325
• Analysis of Sublingual Glycocalyx Damage at ICU Admission to Predict Risk of DeathStatus unknownNCT03847493
• Lidocaine-Ketamine Versus Ketamine for Induction of Anesthesia in Septic Shock PatientsCompletedNCT03844984Phase 3
• Citrulline and Arginase Activity in Severe Sepsis and Septic ShockCompletedNCT03837730
• TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic ShockCompletedNCT03837171Phase 3
• Vitamin C to Reduce Vasopressor Dose in Septic ShockWithdrawnNCT03835286Phase 3
• Usefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit AdmissionStatus unknownNCT03831022
• Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic ShockTerminatedNCT03828929Phase 3
• Effects of Glucocorticoid Combined With Vitamin C and Vitamin B1 on Microcirculation in Severe Septic ShockCompletedNCT03821714Not applicable
• Fluid Responsiveness in HFNC PatientsCompletedNCT03817996
• The Validity of Peripheral Perfusion Index to Predict Fluid ResponsivenessCompletedNCT03805321
• ILOPROST in Septic Shock With Persistent Microperfusion Defects (I-MICRO)CompletedNCT03788837Phase 3
• Peer Support for Post Intensive Care Syndrome Self-ManagementStatus unknownNCT03788096Not applicable
• Electrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septic ShockCompletedNCT03765489Not applicable
• Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic ShockStatus unknownNCT03762005Not applicable
• Ascorbic Acid and Thiamine Effect in Septic ShockCompletedNCT03756220Phase 2
• Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic ShockCompletedNCT03754257Not applicable
• Shenfu Injection Improves Arterial Vascular ReactivityStatus unknownNCT03749525Phase 2/3
• Mitochondrial Function in Septic PatientsCompletedNCT03748537Not applicable
• Severe Septic Shock ComplicationsStatus unknownNCT03716895
• Platelet Reactivity in Septic ShockCompletedNCT03716310
• Macro and Micro Haemodynamic Responses to Shock in the Renal and Systemic - MICROSHOCK - RENALStatus unknownNCT03713307
• Muscle Lactate and Lactate to Pyruvate Ratio Clearance in Septic Shock PatientsCompletedNCT03700346Not applicable
• Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic ShockCompletedNCT03683329Phase 3
• Hepcidin: a Prognostic Marker of Morbidity and Mortality in Severe Sepsis?CompletedNCT03682003
• Fluids in Septic Shock (FISSH)CompletedNCT03677102Phase 2/3
• Evaluation of Fluid Infusion With LifeFlow for Patients With Suspected Septic ShockWithdrawnNCT03673891Not applicable
• Strain Echocardiography During Septic Shock : an Observational Pilot StudyCompletedNCT03663192
• The Effect of Rapid Fluid Challenge Under Pulmonary Artery Catheter Monitoring on Physiological Indexes of Patients With Septic ShockStatus unknownNCT03661268Not applicable
• ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED)CompletedNCT03654001Phase 3
• Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic ShockTerminatedNCT03649633Phase 1/2
• Thiamine As An Adjuvant Therapy For Hyperlactatemia In Septic Shock PatientsStatus unknownNCT03649009Not applicable
• Lidocaine as an Adjuvant for Ketamine in Induction of Anesthesia in Septic Shock PatientsStatus unknownNCT03640468Phase 3
• Treatment of Severe Infection With Antihyperlipidemia DrugStatus unknownNCT03634293Phase 2/3
• Velocity Time Integral vs PICCO for Evaluation of Passive Leg Raising in Septic ShockWithdrawnNCT03621449
• Mortality Due to Septic Shock Associated With ThrombocytopeniaStatus unknownNCT03617965
• Terlipressin Alone Versus the Standard Therapy With Catecholamines for Hepatic Patients With Septic Shock- Prospective Single Center Randomized Controlled Study.Status unknownNCT03608514Phase 2/3
• Vitamin C, Hydrocortisone and Thiamine for Septic ShockTerminatedNCT03592693Phase 2
• Therapeutic Plasma Exchange Adsorption DiafiltrationStatus unknownNCT03589378Not applicable
• Targeting Abdominal Perfusion Pressure in Septic ShockTerminatedNCT03582046Not applicable
• Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical OutcomesStatus unknownNCT03578835
• Clinical Trial of Antioxidant Therapy in Patients With Septic ShockStatus unknownNCT03557229Phase 3
• Thiamine, Vitamin C and Hydrocortisone in the Treatment of Septic ShockCompletedNCT03540628Not applicable
• High Strong Ion Difference Fluid vs Hartmann's Solution on Acid-Base Status in SepsisCompletedNCT03530046Not applicable
• Utility of Sodium Lactate Infusion During Septic ShockCompletedNCT03528213Phase 2/3
• Pharmacokinetics of XueBiJing in Patients With SepsisCompletedNCT03475732Not applicable
• Comparison of Radial and Femoral Artery Site Invasive Blood Pressure Measurement in Septic Shock PatientsCompletedNCT03475667
• TIMP2*IGFBP7 and Transient AKICompletedNCT03472079
• Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic ShockCompletedNCT03461900Not applicable
• Use of Fc-MBL to Detect and Monitor the Presence of PAMPs During Septic ShockStatus unknownNCT03457038Not applicable
• Changes in Microvascular Perfusion During Blood Purification With Cytosorb® in Septic ShockCompletedNCT03456180
• Esomeprazole to Reduce Organ Failure in SepsisCompletedNCT03452865Phase 3
• Survey of Non-resuscitation Fluids in Septic ShockCompletedNCT03438097
• Effects of Dexmedetomidine vs Midazolam on Microcirculation in Septic Shock PatientsStatus unknownNCT03434691Not applicable
• Mean Systemic Filling Pressure Continuous Diuretics Critical Care PatientsCompletedNCT03395951
• Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic ShockTerminatedNCT03380507Phase 2/3
• Heparin Anticoagulation in Septic ShockTerminatedNCT03378466Phase 2
• Cellular Immunotherapy for Septic ShockStatus unknownNCT03369275Phase 2
• Next-Generation Sequencing Diagnostics of Bacteremia in SepsisCompletedNCT03356249
• Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock PatientsCompletedNCT03344627Not applicable
• Early Versus Late CRRT in ACLF Patients With Septic Shock and AKIStatus unknownNCT03343340Not applicable
• Study of Low Carbohydrate Enteral Nutrition in Patients With Bacterial Septic ShockWithdrawnNCT03343041Not applicable
• Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor StudyStatus unknownNCT03336814Phase 4
• The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic ShockTerminatedNCT03335124Phase 4
• The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock TrialCompletedNCT03333278Phase 2
• Plasma and Lung Tissue Concentrations of Linezolid in Septic Shock PatientsStatus unknownNCT03308227
• The Analysis of Factors Influencing the Vd of Imipenem in Septic Shock PatientsCompletedNCT03308214
• Angiotensin II for Septic Shock TreatmentSuspendedNCT03302650Phase 3
• Innate Lymphoid Cells in Septic ShockCompletedNCT03297203Not applicable
• Venous to Arterial Carbon Dioxide Difference (P₍ᵥ-ₐ₎CO₂): Predictor of Septic Patient Prognosis Depending on the ScvO₂CompletedNCT03292120Not applicable
• Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic ShockCompletedNCT03258684Not applicable
• Natriuresis as a Predictor of the Haemodynamic Response to Steroid Replacement Therapy in Patients in Septic ShockCompletedNCT03258619

← Shock, Septic overview